9 ms·
FDA issues first emergency use authorization for point-of-care diagnostic
- hellofunk 7y agoIs this a different test than the 20-minute antibody test discussed here a couple days ago?
- wmf 7y agoYes, it's completely different. That one is a blood test that only detects infections that are pretty far along.
- deleted 7y ago[deleted]
- rootusrootus 7y agoWould it detect resolved infections?
- el_benhameen 7y agoYes, with an outer bound of however long antibodies against the disease persist. That's the big value in that test.
- andrewon 7y agoThis is PCR test. Antibody test generally has lower sensitivity i.e. higher false negative rate because PCR amplifies target molecules.
- gojomo 7y agoI dream that in post-crisis clarity, some news sources will reverse the traditional "FDA as protagonist" wording of such headlines, and instead prefer formulations like: "FDA removes threats of fines & imprisonment for one company's point-of-care COVID-19 diagnostic"
- CPLX 7y agoHow would that help improve people’s understanding of this issue?
- jdavis703 7y agoIt’s the same reason certain folks insist automatic income tax payment schemes would cause people to forget about tax policy.
- gojomo 7y agoThe FDA has no role in creating this test – or any other. They've just dangled a threat of prosecution over companies, hospitals, research labs, and universities who wanted to develop & use a variety of tests – including tests that have proven very useful elsewhere. When they "authorize" something, all they've really done is removed the prior threat of fines & imprisonment. This threat exists even if the thing they're holding up had little to no risk of harm or confusing anyone. (People, especially those in research labs and the medical profession, are not idiots! Even all sorts of long-approved diagnostic tests have significant errors associated that doctors & patients need to discuss & account for! This administrative-law threat exists even if traditional product liability – as applies for all sorts of other product/service/info-product category – would be more than sufficient to ensure quality, & punish recklessness. The FDA's delays have held back US testing capacity for months. The current economic disaster, & many deaths, are a direct outgrowth of both the legislation which gives them this veto-power, and their incompetent exercise of the various discretionary powers they have. They could have offered the same arbitrary waiver that they finally did, on February 29, back in last December! Even now, urgently needed medical supplies are held up, waiting for FDA inspection/certification backlogs to clear: A news story: https://www.washingtonexaminer.com/opinion/fda-inspections-craziness-preventing-coronavirus-response https://www.washingtonexaminer.com/opinion/fda-inspections-c... Testimony from a Google employee & philanthropic investor: https://twitter.com/mekkaokereke/status/1241151194812186624 https://twitter.com/mekkaokereke/status/1241151194812186624 The FDA shouldn't get to tout themselves as doing a good thing with this "authorization" – when the risk of harm of such vitally-necessary new testing options is so small that a delay of days, much less months, is unwarranted. Let scientists, doctors, & patients experiment!
- ck2 7y agoWhere are the 5000/day (hour?) machines doing it for $1 a test? This was promised weeks ago. It was a matter of automated diagnostic reprogramming? So this is promised in 10 days. How many units, 15000?
- rolltiide 7y agoYou mean the one that even the President of the United States couldn’t get at time of press conference?
- penagwin 7y agoThere's not a single person who would agree that the US president is handling this well - For purposes of discussion of COVID19 it's best to just ignore him (I mean this respectfully but seriously).
- sfkdjf9j3j 7y agoThere was actually a poll on Friday that showed 55% of respondents approved of his handling of the crisis.
- salawat 7y agoKeep in mind that all of the data in polls comes from the type of people who respond to random polling with something other than hanging up. I'll admit, I may suffer from the mother of all sampling biases but in the social circles I frequent this is not at all a common trait.
- dmix 7y agoYet these same polls keep accurately predicting primary results on a similar small scale. What we need is more of them and wider samples to reduce the ~95% error rate of the ABC results even lower. Not critiquing ones who have a well established reputation for following good methodology, as if polling never has value (FiveThirtyEight has litigated this to death and have largely won the argument). That said, one poll is rarely ever enough.
- js2 7y agoThis is the device - http://www.cepheid.com/en_US/systems/GeneXpert-Family-of-Systems/GeneXpert-Xpress http://www.cepheid.com/en_US/systems/GeneXpert-Family-of-Sys... Brochure (pdf) - https://p.widencdn.net/jdgicj/Cepheid-GeneXpert-Xpress-System-Brochure-US-IVD-0688-English https://p.widencdn.net/jdgicj/Cepheid-GeneXpert-Xpress-Syste... Promo video - https://www.youtube.com/watch?v=lPTHRqDyWC4 https://www.youtube.com/watch?v=lPTHRqDyWC4 About the size of a small laser printer. I'm not clear how it returns results so quickly. I thought that the RT-PCR process required numerous heating and cooling cycles which is what makes it take as long as it does.
- vikramkr 7y agoI looked at their one of their patents and it looks like they might be using something like rolling circle amplification instead of traditional amplification techniques for faster speed (I don't know off sure but it's one of the options in their claims). Kind of like LAMP pcr where you can amplify really quickly to get a signal really rapidly (although the dna at the end isn't really useable for further synthetic biology - it just provides a strong signal). They also mention a couple other types in this patent like strand displacement etc, so there's a lot of options they could be using. Edit: the keyword to look for might be "isothermal" amplification, which means same - temperature amplification. Again, no clue if that's what they're using, I just see that they have patents on using isothermal techniques. These allow for amplifying DNA without cycling the temperature, usually letting the reaction accelerate quickly until a signal is detected, and it can accelerate really quickly sometimes. You know those videos of supercooled liquid water where you bump the bottle and the whole thing freezes? Imagine that you have a situation like that where adding non-coronavirus dna bumps the bottle incorrectly and nothing happens, while adding coronavirus dna makes the whole thing freezes. It's a rapid signal that just gets generated, but often (like with lamp) you just end up with a polymerizated mess that you can't use for DNA engineering in synthetic biology which is why you might use your temp. cycling methods for those uses. Also, they're good for telling you if something is or isn't there, but not so good at telling you how much dna you started with. To figure that out you again use a cycling reaction with the amount of dna doubling each step until it levels out so you know how many doublings happened and can calculate backwards (quantitative rt-pcr, or qPCR). https://patents.google.com/patent/US8900828 https://patents.google.com/patent/US8900828 https://en.m.wikipedia.org/wiki/Rolling_circle_replication https://en.m.wikipedia.org/wiki/Rolling_circle_replication https://en.m.wikipedia.org/wiki/Loop-mediated_isothermal_amplification https://en.m.wikipedia.org/wiki/Loop-mediated_isothermal_amp...
- neom 7y agoIs this what Theranos was trying to do? (sorry, I'm a n00b!)
- wmf 7y agoIf you mean a machine to automate medical tests, yes. But there are plenty of companies that already make such machines. If you mean a machine to run every possible test using only a few drops of blood, no.
- neom 7y agoAh, thanks! I didn't realize Theranos was trying to do 240 tests on one device.
- btbuildem 7y agoIf this works, it should be open-sourced so it can be manufactured and distributed at multiple locations, in many countries at once.
- pen2l 7y agoI don't think that's going to work because this is a fairly complicated machine, and the company itself which has experience building molecular testing equipment and has a manufacturing supply chain in place is one of the only few that can build this. Also asking them to open-source their technology seems unfair, they're entitled to their share of pay for their hard work. The average engineer at this company probably makes much less than the average engineer at your FAANG company.
- pmiller2 7y agoI wouldn't ask. This is what eminent domain is literally for.
- mlyle 7y agoIf you seize someone's company every time they have a worthwhile breakthrough, that's really going to put a damper on working on problems like this. Not only would you be toiling for uncertain/small reward, you might be flushing your entire business down the toilet. Also, you seize the company-- then what? Are you going to be able to ramp up production, etc, as well as the original product group could? Are you going to make them work on it at gunpoint?
- pmiller2 7y agoShow me another breakthrough in the past 100 years that could save millions of lives right fucking now, and I'll concede you might have a point. Otherwise, you're simply trying to draw a false equivalence.
- dmarchand90 7y agoI agree there's a good point to this. At the same time I dislike and disbelieve the capitalist narrative that the deepest motivation is the profit one.
- AlexCoventry 7y agoHow accurate is it?
- vanniv 7y agoFDA is remarkably quick to authorize things like this test that will make the epidemic look worse, and yet are somehow utterly unwilling to consider authorizing the treatments that have been shown to be effective. I wonder why that is